Hemopoietic stem cell transplant for multiple myeloma (MM)
Barlogie, B.
Leukemia 7(7): 1095
1993
ISSN/ISBN: 0887-6924 PMID: 8100602 Document Number: 418557
Document emailed within 1 workday
Related Documents
Jagannath, S.; Vesole, D.H.; Tricot, G.; Crowley, J.; Salmon, S.E.; Barlogie, B. 1994: Hemopoietic stem cell transplants for multiple myeloma Oncology 8(11): 89Voorhees, P.M.; Usmani, S.Z. 2016: The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy Clinical Advances in Hematology and Oncology: H&o 14(9): 719-728
Boswell, H.S.; Albrecht, P.R.; Shupe, R.E.; Williams, D.E.; Burgess, J. 1987: Role of stromal populations in hemopoietic stem cell proliferation. I. Physically distinct subpopulations of hemopoietic stem cells and stromal progenitors determine long-term culture hemopoiesis Experimental Hematology 15(1): 46-53
Fukuda, S.; Sunami, K.; Sezaki, T. 1999: Stem cell transplantation in multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(10): 1407-1414
Takase, K.; Miyamoto, T. 2015: Allogeneic hematopoietic stem cell transplantation for multiple myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 73(1): 107-113
Jagannath, S. 2009: New drugs in multiple myeloma and the significance of autologous stem cell transplants Clinical Advances in Hematology and Oncology: H&o 7(3): 178-179
Harousseau, J.L.; Attal, M. 1997: The role of autologous hematopoietic stem cell transplantation in multiple myeloma Seminars in Hematology 34(1 Suppl 1: 61-66
Gertz, M.A.; Pineda, A.A.; Chen, M.G.; Letendre, L.; Greipp, P.R.; Solberg, L.A.; Witzig, T.E.; Garton, J.P.; Inwards, D.J.; Litzow, M.R. 1995: Refractory and relapsing multiple myeloma treated by blood stem cell transplantation American Journal of the Medical Sciences 309(3): 152-161
Kumar, L.; Boya, R.R.; Pai, R.; Harish, P.; Mookerjee, A.; Sainath, B.; Patekar, M.B.; Sahoo, R.K.; Malik, P.S.; Sharma, O.D.; Gupta, R. 2016: Autologous stem cell transplantation for multiple myeloma: Long-term results National Medical Journal of India 29(4): 192-199
Erkus, M.; Bolaman, Z.; Meteoglu, I.; Kadikoylu, G. 2005: Localized extramedullary relapse after autologous hematopoietic stem cell transplantation in multiple myeloma Saudi Medical Journal 26(6): 989-991
Subbiah, S.; O'Connell, F.; Kobraei, K.B.; Ramos-Caro, F.A.; Moreb, J.S. 2009: Unusual multiple myeloma cutaneous manifestation following nonmyeloablative allogeneic stem cell transplantation Clinical Advances in Hematology and Oncology: H&o 7(12): 800-802
Krejcí, M.; Hájek, R.; Korístek, Z.; Krivanová, A.; Navrátil, M.; Adam, Z. 2000: Haematopoietic stem cell mobilization in patients with multiple myeloma--comparison of 3 variations of the stimulating regime Vnitrni Lekarstvi 46(8): 439-443
Dreyfus, F.; Ribrag, V.; Leblond, V.; Ravaud, P.; Melle, J.; Quarre, M.C.; Pillier, C.; Boccaccio, C.; Varet, B. 1995: Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma Bone Marrow Transplantation 15(5): 707-711
Kazandjian, D.; Landgren, O. 2019: Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time Clinical Advances in Hematology and Oncology: H&o 17(10): 559-568
Kmonícek, M.; Jebavý, L.; Lánská, M.; Zák, P.; Malý, J.; Maisnar, V. 2000: The treatment of multiple myeloma with an allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen Vnitrni Lekarstvi 46(7): 377-383
Alegre, Aán.; Granda, Aón.; Martínez-Chamorro, C.; Díaz-Mediavilla, Jín.; Martínez, R.; García-Laraña, Jé.; Lahuerta, J-José.; Sureda, A.; Bladé, J.; de la Rubia, J.; Fernández-Rañada, Jé.Maria.; San Miguel, Jús. 2002: Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry Haematologica 87(6): 609-614
Dingli, D.; Rajkumar, S.Vincent.; Nowakowski, G.S.; Gertz, M.A.; Dispenzieri, A.; Lacy, M.Q.; Hayman, S.; Fonseca, R.; Lust, J.A.; Kyle, R.A.; Greipp, P.R.; Witzig, T.E. 2005: Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial Haematologica 90(12): 1650-1654
Patriarca, F.; Gaidano, G.; Capello, D.; Zaja, F.; Fanin, R.; Baccarani, M. 2000: Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation Haematologica 85(9): 982-985
Mohammadi, L.; Harir, N.; Brahimi, M.; Moulessehoul, S.; Bekadja, M.Amine. 2017: Epidemiological, clinical and pronostic aspects of multiple myeloma eligible for therapeutic intensification followed by autologous hematopoietic stem cell in the Algerian West: report of 147 cases La Tunisie Medicale 95(6): 415-421
Duncan, N.; Hewetson, M.; Powles, R.; Raje, N.; Mehta, J. 1996: An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma Bone Marrow Transplantation 18(6): 1175-1178